Sartorius | SRT3 - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 952K 60K 2026-06
Avita Medical AUD 28.56M 534K 2026-06
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
IQVIA Holdings USD 3.82B 2.05B 2026-09
Moderna USD 960M 817M 2026-06
Organon & Co USD 1.19B 187M 2026-09
Revvity USD 604.27M 719K 2026-09
Sartorius EUR 746.5M 1.3M 2026-09
Tectonic Therapeutic USD 24.22M 3.08M 2026-06
Viatris USD 3.68B 145.9M 2026-06
Xeris Pharmaceuticals USD 86.93M 11.72M 2026-06